期刊文献+

氟伐他汀治疗扩张型心肌病的疗效观察

下载PDF
导出
作者 郭红 扬旭明
出处 《中国误诊学杂志》 CAS 2006年第9期1690-1691,共2页 Chinese Journal of Misdiagnostics
  • 相关文献

参考文献5

  • 1齐玉琴,李以宏,葛才荣.他汀类药物临床应用进展[J].中国误诊学杂志,2005,5(5):853-855. 被引量:4
  • 2Kato T,Hashikabe H,Iwata C,et al.Statin blocks Rho/Rho-Kinase signaling and disrupts the avtin cytoskeleton:relationship to enhancement of LPS-mediated niteic oxide synthesis in vascular smooth muscle cell[J].Biophys Acta,2004,1689 (3):267-272.
  • 3赵颖,魏玲,王燕.他汀对稳定型心绞痛患者左室重量的影响[J].中国误诊学杂志,2005,5(3):404-406. 被引量:1
  • 4Ercan E,Tengiz I.Atorvastatin treatment decreases inflammatoryand proteolytic activety in patients withhypercholesterolemia[J].Kardiol Pol,2004,60(5):454-458.
  • 5Takayama T,Wada A,Tsutamoto T,et al.Contribution of vascularNAD(P)H oxidase to endothelial dysfunction in heart failure and the therapeutic effects of HMG-CoA reductase inhibitor[J].Circ J,2004,68(110):1067-1075.

二级参考文献31

  • 1Maron DJ,Fazio S,Linton MF.Current perspective on statins[J].Circulation,2000,101(2):207-213.
  • 2Sever PS,Dahlof B,Pouter NR,et al.Prevention of coronary and stroke events with atorvastatin in hypertension patients who have average or lower-than-average cholesterol concentrations in the Anglo-Scanclinavian Cardiac Outcomes Trial-Lipid Lowering Arm(ASCOT-LLA):a multicentre randomized controlled trial[J].Lancet,2003,361(9364):1149-1158.
  • 3Chilton R,O′ Rourke RA.The expanding role of HMG COA reductase inhibitors (statins) in the prevention and treatment of ischemic heart disease[J].Curr Probl Cardiol,2001,26(12):729.
  • 4Schwartz GG,Olsson AG,Ezekowitz MD,et al.Effects of atorvastatin on early recurrent ischemia events in acute coronary syndrome,the MIRACL study,A randomised clinical trial[J].JAMA,2001,285(3):1711-1718.
  • 5Dupuist J,Tardif TC,Throux P.Cholesterol reduction rapidly improved endothelial function after acute coronary syndrome[J].J Am Coll Cardiol,1998,31(Suppl A):891.
  • 6Foody JM,Nissen SE.Effectiveness of statins in acute coronary syndromes[J]. Am J Cardiol,2001,88(Suppl):31F.
  • 7The post Coronary Artery Bypass Graft Trial Ingestigation. The effect of aggressive lowering of low-density lipoprotein cholesterol levels and low dose anticoagulation on obstructive changes in saphenous-vein coronary artery bypass grafts[J].N Eng J Med,1997,336(3):153-162.
  • 8Charlson ME,Lsom OW.Care after coronary-artery bypass surgery[J].N Eng J Med,2003,348(15):1456-1463.
  • 9Bauersaches J, Galuppo P, Fraccarollo D, et al. Improvement of left ventricular remodeling and function by hydroxy methylglutaryl coenzyme a redutase inhibition with cerivastation in rate with heart failure after myocardial infarction[J].Circulation,2001,104(9):982-985.
  • 10Mitchell LB,Powell JL,Gillis AM,et al.Are lipidlowering drugs also antiarrhythmic drugs? An analysis of the antiarrhythmics versus implantabledefibrillators(AVID) trial[J].J Am Coll Cardiol,2003,42(1):81-87.

共引文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部